Company
Bioventus Inc. (BVS)
Standardized SEC financial data for Bioventus Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001665988 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Gross margin
68.3%
Operating margin
9.5%
Net margin
4.0%
Revenue growth (YoY)
-0.9%
Return on equity
9.9%
ROIC
10.8%
Free cash flow
$72.1M
Debt / equity
1.29×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $321.2M | $430.9M | $512.1M | $512.3M | $573.3M | $568.1M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $86.8M | $99.2M | $31.8M | $37.0M | $41.6M | $51.2M |
| Inventory |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $23.0M | -$13.5M | — | $17.5M | $38.8M | $74.7M |
| Capital expenditures |
Get BVS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BVS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BVS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"